The YouTuber is intrigued by Oscar Health's potential due to its smaller market cap and current profitability, but avoids it for now. He questions its ability to differentiate in the established healthcare insurance market and achieve its 5% operating margin goal, despite its solid growth rate, until there's clearer evidence of sustained efficiency.
“If they are able to grow at a 20% compound annual growth rate, if they are able to get to a 5% operating margin, this would be a phenomenal asymmetric stock.” — ▶ 6:40